Jubilant Pharmo

{
  "main_header": {
    "sid": 525933,
    "name": "Jubilant Pharmo",
    "stock_name": "Jubilant Pharmo",
    "full_name": "Jubilant Pharmova Ltd",
    "name_url": "stocks-analysis/jubilant-pharmo",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "946.80",
    "chg": -4,
    "chgp": "-0.42%",
    "dir": -1,
    "prev_price": "950.80",
    "mcapval": "15,172.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530019,
    "symbol": "JUBLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE700A01033",
    "curr_date": "Jan 21",
    "curr_time": "",
    "bse_nse_vol": "3.73 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 21, 2026",
    "traded_date_str": "2026 01 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jubilant-pharmo-525933-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jubilant Pharmova Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-faces-bearish-momentum-amid-technical-downturn-3797623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JubilantPharmov_technicaldot_3797623.png",
        "date": "2026-01-21 08:01:58",
        "description": "Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The company’s shares have declined sharply in recent weeks, underperforming the broader market and prompting a downgrade in its technical rating to a Sell, reflecting growing investor caution."
      },
      {
        "title": "Jubilant Pharmova Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-forms-death-cross-signalling-potential-bearish-trend-3796935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JubilantPharmov_dealthcross_3796935.png",
        "date": "2026-01-20 18:00:27",
        "description": "Jubilant Pharmova Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-3795946",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JubilantPharmov_mojoScore_3795946.png",
        "date": "2026-01-20 10:10:24",
        "description": "Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jubilant Pharmova Ltd Faces Mildly Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-faces-mildly-bearish-momentum-amid-technical-downgrade-3791303",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JubilantPharmov_technicaldot_3791303.png",
        "date": "2026-01-14 08:01:44",
        "description": "Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Recent technical indicators, including MACD, RSI, and moving averages, signal a cautious outlook for the pharmaceutical and biotechnology company as it navigates market pressures and investor sentiment."
      },
      {
        "title": "Jubilant Pharmova Ltd Faces Technical Momentum Shift Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-faces-technical-momentum-shift-amid-mixed-indicators-3789237",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JubilantPharmov_technicaldot_3789237.png",
        "date": "2026-01-12 08:01:52",
        "description": "Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Recent technical indicators present a complex picture, with bearish signals on key oscillators contrasting with mildly bullish moving averages, reflecting uncertainty in the stock’s near-term trajectory."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-3786728",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JubilantPharmov_mojoScore_3786728.png",
        "date": "2026-01-09 10:10:44",
        "description": "Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3785084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JubilantPharmov_technicaldot_3785084.png",
        "date": "2026-01-08 08:10:00",
        "description": "Jubilant Pharmova Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on daily moving averages, despite mixed signals from key technical indicators such as MACD, RSI, and KST. This nuanced change comes amid a modest price decline and a recent downgrade in its Mojo Grade to Sell, reflecting a complex outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jubilant Pharmova’s Market Assessment Reflects Mixed Signals Across Key Financial and Technical Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-3772568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_mojoScore_3772568.png",
        "date": "2025-12-29 08:02:37",
        "description": "Jubilant Pharmova’s recent market evaluation reveals a nuanced picture shaped by shifts in technical trends, valuation metrics, financial performance, and broader market context. While the pharmaceutical company’s stock price has experienced modest fluctuations, underlying financial indicators and technical signals present a complex landscape for investors to consider."
      },
      {
        "title": "Jubilant Pharmova Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmovas-technical-momentum-shifts-amid-mixed-indicator-signals-3766372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_technicaldot_3766372.png",
        "date": "2025-12-23 08:07:42",
        "description": "Jubilant Pharmova’s stock price momentum has exhibited a subtle shift from a sideways trend to a mildly bullish stance, reflecting nuanced changes in key technical indicators. Despite some bearish signals on longer-term charts, daily moving averages suggest a cautiously optimistic outlook for the pharmaceutical and biotechnology company as it navigates current market conditions."
      }
    ],
    "total": 370,
    "sid": "525933",
    "stock_news_url": "https://www.marketsmojo.com/news/jubilant-pharmova-525933"
  },
  "announcements": [
    {
      "details": "Jubilant Life Sciences Limited has informed the Exchange regarding 'Partial Early Redemption of 4.875% Senior Notes Due 2021 by Jubilant Pharma Limited, wholly-owned subsidiary of the Company (a company incorporated under the laws of Singapore)'.",
      "source": "NSE",
      "caption": "Jubilant Life Sciences Limited - Updates",
      "datetime": "22-Nov-2019"
    },
    {
      "details": "Jubilant Life Sciences Limited has informed the Exchange regarding 'We enclose a communication pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. '.",
      "source": "NSE",
      "caption": "Jubilant Life Sciences Limited - Updates",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "Jubilant Life Sciences Limited has informed the Exchange regarding 'Securities Appellate Tribunal Order",
      "source": "NSE",
      "caption": "Jubilant Life Sciences Limited - Updates",
      "datetime": "08-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has declared <strong>500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has announced <strong>1:5</strong> stock split, ex-date: 17 Mar 06",
          "dt": "2006-03-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jubilant Pharmova Ltd Faces Bearish Momentum Amid Technical Downturn

2026-01-21 08:01:58

Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The company’s shares have declined sharply in recent weeks, underperforming the broader market and prompting a downgrade in its technical rating to a Sell, reflecting growing investor caution.

Read full news article

Jubilant Pharmova Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-01-20 18:00:27

Jubilant Pharmova Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook.

Read full news article

Jubilant Pharmova Ltd is Rated Sell

2026-01-20 10:10:24

Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jubilant Pharmova Ltd Faces Mildly Bearish Momentum Amid Technical Downgrade

2026-01-14 08:01:44

Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Recent technical indicators, including MACD, RSI, and moving averages, signal a cautious outlook for the pharmaceutical and biotechnology company as it navigates market pressures and investor sentiment.

Read full news article

Jubilant Pharmova Ltd Faces Technical Momentum Shift Amid Mixed Indicators

2026-01-12 08:01:52

Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Recent technical indicators present a complex picture, with bearish signals on key oscillators contrasting with mildly bullish moving averages, reflecting uncertainty in the stock’s near-term trajectory.

Read full news article

Jubilant Pharmova Ltd is Rated Sell

2026-01-09 10:10:44

Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-08 08:10:00

Jubilant Pharmova Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on daily moving averages, despite mixed signals from key technical indicators such as MACD, RSI, and KST. This nuanced change comes amid a modest price decline and a recent downgrade in its Mojo Grade to Sell, reflecting a complex outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Jubilant Pharmova’s Market Assessment Reflects Mixed Signals Across Key Financial and Technical Metrics

2025-12-29 08:02:37

Jubilant Pharmova’s recent market evaluation reveals a nuanced picture shaped by shifts in technical trends, valuation metrics, financial performance, and broader market context. While the pharmaceutical company’s stock price has experienced modest fluctuations, underlying financial indicators and technical signals present a complex landscape for investors to consider.

Read full news article

Jubilant Pharmova Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-23 08:07:42

Jubilant Pharmova’s stock price momentum has exhibited a subtle shift from a sideways trend to a mildly bullish stance, reflecting nuanced changes in key technical indicators. Despite some bearish signals on longer-term charts, daily moving averages suggest a cautiously optimistic outlook for the pharmaceutical and biotechnology company as it navigates current market conditions.

Read full news article

View All News